- Home
- LAB vs CMPS Comparison
LAB vs CMPS Comparison
Compare LAB & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- CMPS
- Stock Information
- Founded
- LAB 1999
- CMPS 2020
- Country
- LAB United States
- CMPS United Kingdom
- Employees
- LAB N/A
- CMPS N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- LAB Industrials
- CMPS Health Care
- Exchange
- LAB Nasdaq
- CMPS Nasdaq
- Market Cap
- LAB 372.1M
- CMPS 364.9M
- IPO Year
- LAB 2011
- CMPS 2020
- Fundamental
- Price
- LAB $1.34
- CMPS $3.68
- Analyst Decision
- LAB Buy
- CMPS Strong Buy
- Analyst Count
- LAB 2
- CMPS 7
- Target Price
- LAB $2.50
- CMPS $17.83
- AVG Volume (30 Days)
- LAB 2.8M
- CMPS 5.0M
- Earning Date
- LAB 07-30-2025
- CMPS 07-31-2025
- Dividend Yield
- LAB N/A
- CMPS N/A
- EPS Growth
- LAB N/A
- CMPS N/A
- EPS
- LAB N/A
- CMPS N/A
- Revenue
- LAB $169,687,000.00
- CMPS N/A
- Revenue This Year
- LAB N/A
- CMPS N/A
- Revenue Next Year
- LAB $12.18
- CMPS N/A
- P/E Ratio
- LAB N/A
- CMPS N/A
- Revenue Growth
- LAB 33.86
- CMPS N/A
- 52 Week Low
- LAB $0.92
- CMPS $2.25
- 52 Week High
- LAB $2.41
- CMPS $8.54
- Technical
- Relative Strength Index (RSI)
- LAB 58.76
- CMPS 50.85
- Support Level
- LAB $1.27
- CMPS $2.25
- Resistance Level
- LAB $1.41
- CMPS $3.50
- Average True Range (ATR)
- LAB 0.11
- CMPS 0.31
- MACD
- LAB 0.01
- CMPS 0.07
- Stochastic Oscillator
- LAB 50.00
- CMPS 87.42
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.